169 related articles for article (PubMed ID: 38680496)
1. Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types.
Kim DK; Lee CY; Han YJ; Park SY; Han H; Na K; Kim MH; Yang SM; Baek S; Kim Y; Hwang JY; Lee S; Kang SS; Hong MH; Lim SM; Lee JB; Kim JH; Cho BC; Pyo KH
Front Immunol; 2024; 15():1330228. PubMed ID: 38680496
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
Mo Z; Li P; Cao Z; Zhang S
Front Immunol; 2021; 12():564948. PubMed ID: 34290693
[TBL] [Abstract][Full Text] [Related]
3. The Aryl Hydrocarbon Receptor and Tumor Immunity.
Xue P; Fu J; Zhou Y
Front Immunol; 2018; 9():286. PubMed ID: 29487603
[TBL] [Abstract][Full Text] [Related]
4. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
5. Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Kober C; Roewe J; Schmees N; Roese L; Roehn U; Bader B; Stoeckigt D; Prinz F; Gorjánácz M; Roider HG; Olesch C; Leder G; Irlbacher H; Lesche R; Lefranc J; Oezcan-Wahlbrink M; Batra AS; Elmadany N; Carretero R; Sahm K; Oezen I; Cichon F; Baumann D; Sadik A; Opitz CA; Weinmann H; Hartung IV; Kreft B; Offringa R; Platten M; Gutcher I
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37963637
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
7. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
[TBL] [Abstract][Full Text] [Related]
8. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
Megna BW; Carney PR; Depke MG; Nukaya M; McNally J; Larsen L; Rosengren RJ; Kennedy GD
J Surg Res; 2017 Jun; 213():16-24. PubMed ID: 28601309
[TBL] [Abstract][Full Text] [Related]
9. Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
Lee CC; Yang WH; Li CH; Cheng YW; Tsai CH; Kang JJ
Cancer Lett; 2016 Jul; 376(2):211-7. PubMed ID: 27060206
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling.
Ye M; Zhang Y; Gao H; Xu Y; Jing P; Wu J; Zhang X; Xiong J; Dong C; Yao L; Zhang J; Zhang J
Clin Cancer Res; 2018 Mar; 24(5):1227-1239. PubMed ID: 29229632
[No Abstract] [Full Text] [Related]
11. Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.
Lahoti TS; Boyer JA; Kusnadi A; Muku GE; Murray IA; Perdew GH
Toxicol Sci; 2015 Nov; 148(1):229-40. PubMed ID: 26259605
[TBL] [Abstract][Full Text] [Related]
12. Expression of aryl hydrocarbon receptor in rat brain lesions following traumatic brain injury.
Xu K; Yang Z; Shi R; Luo C; Zhang Z
Diagn Pathol; 2016 Aug; 11(1):72. PubMed ID: 27506546
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
Brinkman AM; Wu J; Ersland K; Xu W
BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines.
Vorrink SU; Severson PL; Kulak MV; Futscher BW; Domann FE
Toxicol Appl Pharmacol; 2014 Feb; 274(3):408-16. PubMed ID: 24355420
[TBL] [Abstract][Full Text] [Related]
15. Tumour Microenvironment: Roles of the Aryl Hydrocarbon Receptor, O-GlcNAcylation, Acetyl-CoA and Melatonergic Pathway in Regulating Dynamic Metabolic Interactions across Cell Types-Tumour Microenvironment and Metabolism.
Anderson G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375613
[TBL] [Abstract][Full Text] [Related]
16. Effects of human blood levels of two PAH mixtures on the AHR signalling activation pathway and CYP1A1 and COMT target genes in granulosa non-tumor and granulosa tumor cell lines.
Zajda K; Ptak A; Rak A; Fiedor E; Grochowalski A; Milewicz T; Gregoraszczuk EL
Toxicology; 2017 Aug; 389():1-12. PubMed ID: 28710019
[TBL] [Abstract][Full Text] [Related]
17. The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation.
Kenison JE; Wang Z; Yang K; Snyder M; Quintana FJ; Sherr DH
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33941684
[TBL] [Abstract][Full Text] [Related]
18. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
19. Induction of aryl hydrocarbon receptor in granulosa cells by endoplasmic reticulum stress contributes to pathology of polycystic ovary syndrome.
Kunitomi C; Harada M; Kusamoto A; Azhary JM; Nose E; Koike H; Xu Z; Urata Y; Takahashi N; Wada-Hiraike O; Hirota Y; Koga K; Fujii T; Osuga Y
Mol Hum Reprod; 2021 Feb; 27(3):. PubMed ID: 33493289
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor, a tumor grade‑associated marker of oral cancer, is directly downregulated by polydatin: A pilot study.
Martano M; Stiuso P; Facchiano A; De Maria S; Vanacore D; Restucci B; Rubini C; Caraglia M; Ravagnan G; Lo Muzio L
Oncol Rep; 2018 Sep; 40(3):1435-1442. PubMed ID: 30015848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
